Top 200 Drugs Podcast – Medications 131-135
Real Life Pharmacology - Pharmacology Education for Health Care Professionals - Un podcast de Eric Christianson, PharmD; Pharmacology Expert and Clinical Pharmacist - Les jeudis
Catégories:
On this episode of the Top 200 drugs podcast from Real Life Pharmacology, I cover medications 131-135 which include enoxaparin, methylphenidate, rosuvastatin, denosumab, and dabigatran. Enoxaparin is an injectable anticoagulant that can cause heparin-induced thrombocytopenia. Methylphenidate is a stimulant medication that can be used to treat ADHD. Cardiovascular adverse effects are possible. Rosuvastatin inhibits HMG-CoA Reductase which helps lower LDL in the management of hypercholesterolemia. Denosumab is a monoclonal antibody that is indicated for osteoporosis and may cause hypocalcemia. Dabigatran was one of the first direct oral anticoagulants to be produced. It is dosed twice daily and has warnings about use in patients over the age of 75.
